Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Invivoscribe, Inc., a vertically integrated global company focused on Improving Lives with Precision Diagnostics
®, today announces expansion of space and testing capabilities in their international network of accredited LabPMM® clinical laboratories. Additions to the test menu will include morphology, IHC, flow cytometry, as well as the latest multiparameter flow- (MPF), and NGS-based minimal residual disease (MRD) testing of primary specimens. These new services will further support rapid patient diagnosis, study subject enrollment, and study subject stratifications. They will be available by end of this year in San Diego followed by the laboratories in Japan, Germany and China.
“Our comprehensive test menu will eliminate the need for partners to split primary specimens, dramatically decreasing turnaround times and accelerating receipt of comprehensive test reports. This is especially important for partners performing international clinical trials, as enrollment in frontline therapies often requires timely testing and reporting, which can be delayed when using multiple vendors,” said Dr. Jeffrey Miller, CSO & CEO.
“Rapid generation of test results improves enrollment rates, often an important barrier in completing clinical trials. Generation of internationally standardized test results mitigates risk by ensuring cohorts are homogeneous and arms are properly balanced. Reducing variables collapses timelines for regulatory submissions and accelerates approvals of novel new therapies. Patients in critical need of new therapies will ultimately be the big winners here,” he added.
“In addition, regulatory agencies and our partners are requesting a combination of MPF and NGS-based MRD testing; coherent comparison of these MRD test results can only happen if testing is done intramurally on the same specimens, drawn at the same time, using well validated standardized tests. Our tests and associated software are developed under design controls to meet relevant international regulatory requirements.”
Invivoscribe’s wholly-owned LabPMM laboratories are accredited per regional requirements (e.g. CAP, New York State-license, ISO 15189, RiliBÄK, Kawasaki City, etc.) and are the only clinical reference laboratories offering tests with bioinformatics software developed and manufactured by Invivoscribe in its FDA-registered cGMP facility.
Invivoscribe has acquired additional contiguous space for its accredited laboratories in San Diego, Japan, Germany, and China. Greater than 95% of patient samples tested using their FDA-approved LeukoStrat® CDx FLT3 Mutation Assay and selection of other CLIA-validated PCR-based capillary assays report out results within 48 hours of sample receipt at any of their LabPMM laboratories. A number of their NGS-based MRD assays, such as their LymphoTrack® assays, can achieve limits of detection of 10-6 for those requiring that level of sensitivity.
Invivoscribe is a privately held biotechnology company. Now in its twenty-fifth year of operation, Invivoscribe has improved the quality of healthcare worldwide by providing high quality, standardized reagents, tests, and bioinformatics tools to advance the field of precision medicine. Invivoscribe has a successful track record of partnerships with global pharmaceutical companies interested in developing and commercializing companion diagnostics, and provides expertise in both regulatory and laboratory services. Providing distributable kits, as well as clinical trial services through its globally located clinical lab subsidiaries (LabPMM), Invivoscribe is an ideal partner from diagnostic development, through clinical trials, regulatory submissions, and commercialization.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Sanan IC Expands Wafer Foundry Portfolio for Power Electronics with 150mm GaN-on-Silicon Process24.6.2019 15:00:00 CEST | Pressemelding
SUNNYVALE, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- SANAN INTEGRATED CIRCUIT CO., LTD. (Sanan IC), a pure-play wafer foundry with its advanced compound semiconductor technology platform, today announced the commercial release of its 150mm gallium nitride (GaN) on silicon wafer foundry services intended for the latest high voltage AC/DC and DC/AC power electronics applications in the global market. Sanan IC’s new G06P111 is a 650V enhanced-mode high-electron-mobility transistor (E-HEMT) GaN process which adds to the company’s power electronics wafer foundry portfolio of wide bandgap (WBG) compound semiconductors that includes 100mm and 150mm silicon carbide (SiC) for high voltage Schottky Barrier Diodes (SBD). Leveraging years of high volume GaN manufacturing experience by Sanan Optoelectronics Inc., its parent company, for the LED market, Sanan IC is able to complement its foundry services with in-house MOCVD growth capabilities of high voltage, low leakage GaN-on-silicon epitaxial wa
Nasdaq Promotes Tal Cohen to Executive Vice President, North American Market Services24.6.2019 14:30:00 CEST | Pressemelding
Tom Wittman to become Executive Advisor and to retire from Nasdaq at year-end NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Nasdaq, Inc. today announced it has named Tal Cohen as Executive Vice President, North American Market Services, effective July 1. In this role, Cohen will be responsible for driving the strategy and success of our trading businesses across cash equities, commodities, derivatives, and trade management services in Nasdaq’s U.S. and Canadian markets. In his role, in addition to directing the strategy of the business, Cohen will oversee Nasdaq’s North American trading products across their lifecycle and will manage client relationships and market operations. He will report to Adena Friedman, President and CEO, Nasdaq. Cohen joined Nasdaq in April 2016 as Senior Vice President of North American Equities following the acquisition of Chi-X Canada, where he had served as CEO of Chi-X Global Holdings for six years. Prior to Chi-X, Cohen held senior positions at Instinet, Am
U.S. Army awards Vricon contract for One World Terrain24.6.2019 14:30:00 CEST | Pressemelding
Vricon to apply its Globe in 3D solution to support military training anywhere in the world McLean, VA, June 24, 2019 (GLOBE NEWSWIRE) -- Vricon is pleased to announce that on 14 June 2019, the U.S. Army, working through the Training and Readiness Accelerator, awarded Vricon an Other Transaction Agreement to build One World Terrain (OWT). One of the key objectives of OWT is to provide an accurate and realistic 3D global terrain that replicates the military’s operational environment. Specifically, OWT is part of the Synthetic Training Environment's Common Synthetic Environment (CSE). The CSE is the platform enabler of the Synthetic Training Environment that will allow units and soldiers to conduct realistic, multi-echelon collective training anywhere in the world. The Common Synthetic Environment is composed of three foundational capabilities: One World Terrain, Training Management Tool, and Training Simulation Software. “We are honored that the Army chose the Vricon solution for its On
WorkForce Software Announces Strategic Growth Investment from Evergreen Coast Capital24.6.2019 14:00:00 CEST | Pressemelding
Investment to Accelerate WorkForce Software’s Global Expansion and Commitment to Customer-First Innovation LIVONIA, Mich., June 24, 2019 (GLOBE NEWSWIRE) -- WorkForce Software®, a leading global provider of cloud-based workforce management solutions, announced today a significant equity investment from affiliates of Evergreen Coast Capital Corp. (“Evergreen”), the technology-focused private equity arm of Elliott Management Corporation. With the investment, Evergreen will become equal partners with Insight Partners, which has been the majority investor in WorkForce Software since 2014. Terms of the transaction were not disclosed. Founded in 1999, WorkForce Software is making work easy for the connected workforce around the globe. The company’s cloud-based solutions enable enterprise and mid-sized organizations to digitize time and attendance processes, optimize employee scheduling, simplify absence management, and gain strategic business insights. WorkForce Software was the first workfo
Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia24.6.2019 13:30:00 CEST | Pressemelding
Primary endpoint, defined as Latency to Persistent Sleep (LPS) at Night 1, showed improvement with a p-value ≤0.001 after treatment with 10 and 20 mg doses of seltorexant Key secondary endpoint, defined as Wake After Sleep Onset over first 6 hours (WASO‑6) at Night 1, showed improvement with a p-value ≤0.005 after treatment with 10 and 20 mg doses of seltorexant Treatment with 10 and 20 mg doses of seltorexant showed greater improvement compared to zolpidem in LPS and WASO-6 Beneficial effects maintained over time Effects consistent in both adult and elderly patients Safety and tolerability profile comparable to placebo in both adults and elderly Potential first-in-class specific orexin-2 receptor antagonist for the treatment of insomnia Company to host conference call at 8:30 a.m. today (dial-in information below) WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therap
Camunda Announces Extensive Speaker Lineup for CamundaCon 201924.6.2019 09:00:00 CEST | Pressemelding
Early Bird Tickets for the annual Camunda Community event available until June 30 BERLIN, June 24, 2019 (GLOBE NEWSWIRE) -- Camunda, an open source software company reinventing workflow automation, today announced the speaker lineup for its annual user conference – CamundaCon – featuring presenters from LinkedIn, Roche and AXA, among others. Demand for the tech-focused event is significantly outpacing last year and discounted Early Bird tickets are available only until June 30. CamundaCon, an event created for software developers, enterprise architects and IT executives who want to learn about workflow and decision automation, takes place September 12-13 in the heart of Berlin. It brings together workflow automation and BPMN experts, the global Camunda community and the Camunda engineering team to share best practices, discuss the product roadmap and get inspiration from fellow Camunda users. New this year to the annual conference is a developer-focussed track, with dedicated tutorials